The accuracy of Vesical Imaging-Reporting and Data System (VI-RADS): an updated comprehensive multi-institutional, multi-readers systematic review and meta-analysis from diagnostic evidence into future clinical recommendations - Summary - MDSpire

The accuracy of Vesical Imaging-Reporting and Data System (VI-RADS): an updated comprehensive multi-institutional, multi-readers systematic review and meta-analysis from diagnostic evidence into future clinical recommendations

  • By

  • Francesco Del Giudice

  • Rocco Simone Flammia

  • Martina Pecoraro

  • Marco Moschini

  • David D’Andrea

  • Emanuele Messina

  • Lucia Martina Pisciotti

  • Ettore De Berardinis

  • Alessandro Sciarra

  • Valeria Panebianco

  • March 16, 2022

  • 0 min

Share

Objective:

To assess the cumulative diagnostic performance of VI-RADS scoring criteria for distinguishing between non-muscle invasive bladder cancer (NMIBC) and muscle invasive bladder cancer (MIBC) clinical staging, and to evaluate the pooled diagnostic performance among different genito-urinary (GU) readers and MRI scanners.

Key Findings:
  • VI-RADS shows promising performance in distinguishing NMIBC from MIBC, which could significantly impact clinical decision-making.
  • Previous meta-analyses had limitations in statistical power and variability in reader experience and MRI technology.
  • Optimal diagnostic settings, reproducibility, and threshold cut-off criteria for VI-RADS remain unresolved, necessitating further investigation.
Interpretation:

The findings suggest that while VI-RADS is a valuable tool for bladder cancer staging, further research is needed to standardize its application and improve diagnostic accuracy across different clinical settings, which could enhance patient outcomes.

Limitations:
  • Limited granularity in previous studies due to small sample sizes, which may affect the reliability of the findings.
  • Variability in MRI scanners and reader experience may affect outcomes, highlighting the need for standardized protocols.
  • Lack of consensus on appropriate VI-RADS cut-off thresholds, which complicates clinical application.
Conclusion:

The systematic review highlights the need for further dedicated clinical trials to validate VI-RADS and establish standardized diagnostic protocols for muscle invasion assessment in bladder cancer, addressing the identified limitations to improve diagnostic accuracy.

Original Source(s)

Related Content